The Clorox Company
General ticker "CLX" information:
- Sector: Consumer Staples
- Industry: Household & Personal Products
- Capitalization: $13.8B (TTM average)
The Clorox Company does not follow the US Stock Market performance with the rate: -25.6%.
Estimated limits based on current volatility of 2.1%: low 95.25$, high 99.37$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-08-12, amount 1.25$ (Y5.30%)
- Total employees count: 7600 (-5.0%) as of 2025
- US accounted for 84.0% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Economic downturns and volatility, Market competition, Supply chain disruptions, Cybersecurity threats, Regulatory and compliance
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [75.27$, 118.52$]
- 2027-06-30 to 2028-06-29 estimated range: [76.50$, 119.82$]
Financial Metrics affecting the CLX estimates:
- Negative: with PPE of 17.1 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 24.73 > 18.77
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.16 > 6.06
- Positive: -9.15 < Industry operating profit margin (median), % of 0.70
- Positive: Shareholder equity ratio, % of 1.15 <= 18.97
- Negative: 0.75 < Interest expense per share per price, % of 1.13
- Positive: Industry inventory ratio change (median), % of -0.05 <= 0
Short-term CLX quotes
Relationship graph
Long-term CLX plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $7,093.00MM | $7,104.00MM | $6,720.00MM |
| Operating Expenses | $6,177.00MM | $5,925.00MM | $5,058.00MM |
| Operating Income | $916.00MM | $1,179.00MM | $1,662.00MM |
| Non-Operating Income | $-518.00MM | $-101.00MM | $-871.00MM |
| Interest Expense | $90.00MM | $88.00MM | $130.00MM |
| R&D Expense | $126.00MM | $121.00MM | $116.00MM |
| Income(Loss) | $398.00MM | $1,078.00MM | $791.00MM |
| Taxes | $106.00MM | $254.00MM | $190.00MM |
| Net Income(Loss)* | $280.00MM | $810.00MM | $587.00MM |
| Stockholders Equity | $328.00MM | $321.00MM | $90.00MM |
| Inventory | $637.00MM | $523.00MM | $777.00MM |
| Assets | $5,751.00MM | $5,561.00MM | $7,794.00MM |
| Operating Cash Flow | $695.00MM | $981.00MM | $612.00MM |
| Capital expenditure | $212.00MM | $220.00MM | $207.00MM |
| Investing Cash Flow | $-175.00MM | $-94.00MM | $-2,301.00MM |
| Financing Cash Flow | $-655.00MM | $-924.00MM | $1,668.00MM |
| Earnings Per Share** | $2.25 | $6.56 | $4.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.